Lozano, Guillermina
- UT MD Anderson Cancer Center · Genetics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #12,356
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Genetics
NIH Funding · FY2023
Linked Award Amount
$851.3K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#12,356
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Lozano, Guillermina as a PI. Multi-PI records show the full award amount for context.
- 5R01CA047296-35R01Contact PIA Pathway of Tumor SuppressionUT MD Anderson Cancer Center · Genetics (NIH department code)$466.6Kaward amount
- 5R01CA082577-24R01Contact PIRole of p53 Missense Mutations on Tumorigenesis in VivoUT MD Anderson Cancer Center · Genetics (NIH department code)$384.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Lozano, Guillermina as a PI.
FY2023 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUT MD Anderson Cancer Center
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #6166
- 2007$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2012$5M Cumulative Funding
- 2012R01 Grant Holder
- 2018$10M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #2278